DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

Emergent BioSolutions (NYSE: EBS)

32.49 -0.17 (-0.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EBS $32.49 -0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.25
Previous Close $32.66
Daily Range $32.07 - $32.94
52-Week Range $19.31 - $36.20
Market Cap $1.3B
P/E Ratio 29.69
Dividend (Yield) $0.00 (0.0%)
Volume 163,769
Average Daily Volume 298,654
Current FY EPS $1.43

Sector

Healthcare

Industry

Drug Makers

Emergent BioSolutions (EBS) Description

Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/

News & Commentary

A Breakup at Emergent BioSolutions

The biodefense specialist announced plans to spin off its biosciences division.

Emergent BioSolutions Gets $44M CDC Contract for VIGIV

Emergent BioSolutions Receives $44M CDC Contract to Further Advance Vaccinia Immune Globulin Intrave

Emergent BioSolutions Receives $44M CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program

Emergent BioSolutions Tops on Q2 Earnings, Plans Spin-Off - Analyst Blog

Health Care Sector Update for 08/06/2015: DVA, TTPH, EBS

Emergent BioSolutions' (EBS) CEO Daniel Abdun-Nabi on Q2 2015 Results - Earnings Call Transcript

Emergent BioSolutions (EBS) Q2 2015 Results - Earnings Call Webcast

Emergent BioSolutions to Spin-Off of Biosciences Business Into Separate Publicly-Traded Company in T

Emergent BioSolutions to Spin-Off of Biosciences Business Into Separate Publicly-Traded Company in Tax-Free Transaction

Don't Miss Today's Strong And Under The Radar Stock: Emergent BioSolutions (EBS)

UPDATE: Emergent Biosolutions Announces $19.7M Contract

See More EBS News...

EBS's Top Competitors

EBS $32.49 (-0.52%)
Current stock: EBS
AMGN $147.02 (-1.48%)
Current stock: AMGN
GILD $102.06 (0.15%)
Current stock: GILD
BIIB $302.26 (0.21%)
Current stock: BIIB